SCHEMBL46470

SCHEMBL46470

O=C(O)c1cccc(C(=O)Nc2ccc(Cl)cc2-c2cc(NCc3cccc(C(F)(F)F)c3)ncn2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 2/20 0.48
CDC7 O00311 1/20 0.48
ROCK2 O75116 1/20 0.48
MAP4K4 O95819 1/20 0.48
PIM1 P11309 1/20 0.48
PRKACA P17612 1/20 0.48
CDK2 P24941 1/20 0.48
GSK3B P49841 1/20 0.48
HIPK2 Q9H2X6 1/20 0.48
MKNK2 Q9HBH9 1/20 0.48
IRAK4 Q9NWZ3 1/20 0.48
PPARG P37231 2/20 0.47
PPARD Q03181 2/20 0.47
NR1H4 Q96RI1 2/20 0.47
LOXL2 Q9Y4K0 1/20 0.46
MRGPRX4 Q96LA9 2/20 0.45
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40589 0.91 ROCK2 (0.46) CLK4CDC7ROCK2MAP4K4PIM1
SCHEMBL15432596 0.87 CYP1A2 (0.55) CLK4CDC7ROCK2PIM1PRKACA
SCHEMBL46461 0.87 SLC34A2 (0.54) CLK4CDC7ROCK2MAP4K4PIM1
SCHEMBL46471 0.87 SLC34A2 (0.46) CLK4CDC7ROCK2MAP4K4PIM1
SCHEMBL18059178 0.85 CLK4 (0.49) CLK4CDC7ROCK2MAP4K4PIM1
SCHEMBL6001515 0.84 SLC34A2 (0.42) CLK4CDC7ROCK2MAP4K4PIM1
SCHEMBL46732 0.83 CDC7 (0.41) CLK4CDC7ROCK2MAP4K4PIM1
SCHEMBL15432592 0.79 CYP1A2 (0.53) CLK4CDC7ROCK2PIM1PRKACA
SCHEMBL39097 0.78 CLK4 (0.58) CLK4CDC7ROCK2MAP4K4PIM1
SCHEMBL2720505 0.77 SLC34A2 (0.56) PPARGPPARDNR1H4MRGPRX4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590656-B1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX INC (US) 2017-11-15 EP disclosed
US-20170037010-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. 2017-02-09 US disclosed
US-9301951-B2 Compounds and methods for inhibiting phosphate transport ARDELYX, INC. (US) 2016-04-05 US disclosed
US-20150164876-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. 2015-06-18 US disclosed
US-8916569-B2 Compounds and methods for inhibiting phosphate transport ARDELYX, INC. (US) 2014-12-23 US disclosed
US-20140023611-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. 2014-01-23 US disclosed
WO-2012054110-A2 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. (US) 2012-04-26 WO disclosed
WO-2012006475-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. (US) 2012-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164876-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT SLC34A2, SLC34A1, SLC10A2 CLK4 2790/4885CDC7 2129/4885ROCK2 2489/4885
US-20170037010-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT SLC34A2, SLC34A1, SLC10A2 CLK4 2790/4885CDC7 2129/4885ROCK2 2489/4885
US-20140023611-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT SLC10A2, SLC34A2, SLC34A3 CLK4 3265/4885CDC7 1709/4885ROCK2 3729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.